These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 18664303

  • 1. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF, Reid MS, De La Garza R, Mahoney JJ, Abad A, Condos R, Palamar J, Halkitis PN, Mojisak J, Anderson A, Li SH, Elkashef A.
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [Abstract] [Full Text] [Related]

  • 2. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T, Matsuda Y, Iwata N, Correll CU.
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [Abstract] [Full Text] [Related]

  • 3. Compulsive methamphetamine taking under punishment is associated with greater cue-induced drug seeking in rats.
    Torres OV, Jayanthi S, Ladenheim B, McCoy MT, Krasnova IN, Cadet JL.
    Behav Brain Res; 2017 May 30; 326():265-271. PubMed ID: 28284948
    [Abstract] [Full Text] [Related]

  • 4. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.
    Lile JA, Stoops WW, Vansickel AR, Glaser PE, Hays LR, Rush CR.
    Neuropsychopharmacology; 2005 Nov 30; 30(11):2103-14. PubMed ID: 15988473
    [Abstract] [Full Text] [Related]

  • 5. Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.
    Stoops WW, Bennett JA, Lile JA, Sevak RJ, Rush CR.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec 02; 47():111-7. PubMed ID: 23994622
    [Abstract] [Full Text] [Related]

  • 6. A virtual reality counterconditioning procedure to reduce methamphetamine cue-induced craving.
    Wang YG, Liu MH, Shen ZH.
    J Psychiatr Res; 2019 Sep 02; 116():88-94. PubMed ID: 31226580
    [Abstract] [Full Text] [Related]

  • 7. Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.
    De La Garza R, Newton TF, Haile CN, Yoon JH, Nerumalla CS, Mahoney JJ, Aziziyeh A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr 27; 37(1):141-6. PubMed ID: 22230648
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.
    De La Garza R, Zorick T, London ED, Newton TF.
    Drug Alcohol Depend; 2010 Jan 15; 106(2-3):173-80. PubMed ID: 19781865
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis.
    Sulaiman AH, Gill JS, Said MA, Zainal NZ, Hussein HM, Guan NC.
    Int J Psychiatry Clin Pract; 2013 Jun 15; 17(2):131-8. PubMed ID: 22486597
    [Abstract] [Full Text] [Related]

  • 10. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.
    De La Garza R, Mahoney JJ, Culbertson C, Shoptaw S, Newton TF.
    Pharmacol Biochem Behav; 2008 Apr 15; 89(2):200-8. PubMed ID: 18207225
    [Abstract] [Full Text] [Related]

  • 11. Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers.
    Liu Y, Sun HQ, Bao YP, Li SX, Beveridge TJ, Di XL, Yang FD, Lu L.
    Drug Alcohol Depend; 2009 Apr 01; 101(1-2):42-52. PubMed ID: 19070440
    [Abstract] [Full Text] [Related]

  • 12. Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
    Stoops WW.
    Exp Clin Psychopharmacol; 2006 Nov 01; 14(4):413-21. PubMed ID: 17115868
    [Abstract] [Full Text] [Related]

  • 13. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers.
    De La Garza R, Zorick T, Heinzerling KG, Nusinowitz S, London ED, Shoptaw S, Moody DE, Newton TF.
    Pharmacol Biochem Behav; 2009 Nov 01; 94(1):186-93. PubMed ID: 19698734
    [Abstract] [Full Text] [Related]

  • 14. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.
    Schepers RJ, Oyler JM, Joseph RE, Cone EJ, Moolchan ET, Huestis MA.
    Clin Chem; 2003 Jan 01; 49(1):121-32. PubMed ID: 12507968
    [Abstract] [Full Text] [Related]

  • 15. Detection of patients with methamphetamine dependence with cue-elicited heart rate variability in a virtual social environment.
    Wang YG, Shen ZH, Wu XC.
    Psychiatry Res; 2018 Dec 01; 270():382-388. PubMed ID: 30300868
    [Abstract] [Full Text] [Related]

  • 16. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
    Stoops WW, Lile JA, Glaser PE, Rush CR.
    Drug Alcohol Depend; 2006 Sep 15; 84(2):206-9. PubMed ID: 16540264
    [Abstract] [Full Text] [Related]

  • 17. Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.
    Wee S, Wang Z, Woolverton WL, Pulvirenti L, Koob GF.
    Neuropsychopharmacology; 2007 Oct 15; 32(10):2238-47. PubMed ID: 17327886
    [Abstract] [Full Text] [Related]

  • 18. Aripiprazole maintenance increases smoked cocaine self-administration in humans.
    Haney M, Rubin E, Foltin RW.
    Psychopharmacology (Berl); 2011 Aug 15; 216(3):379-87. PubMed ID: 21373790
    [Abstract] [Full Text] [Related]

  • 19. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K.
    Neuropsychopharmacology; 2015 Sep 15; 40(10):2347-56. PubMed ID: 25801501
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia.
    Boulton DW, Kollia G, Mallikaarjun S, Komoroski B, Sharma A, Kovalick LJ, Reeves RA.
    Clin Pharmacokinet; 2008 Sep 15; 47(7):475-85. PubMed ID: 18563956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.